Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

MMirum Pharmaceuticals, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
M

Mirum Pharmaceuticals, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
    Sep 25, 2026Mirum Pharmaceuticals, Inc. Press Releases
  • Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Sep 14, 2026Mirum Pharmaceuticals, Inc. Press Releases
  • Mirum Pharmaceuticals Appoints Dr. Rob Myers as Chief Medical Officer
    Sep 8, 2026Mirum Pharmaceuticals, Inc. Press Releases
  • Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
    Sep 2, 2026Mirum Pharmaceuticals, Inc. Press Releases
  • Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Aug 11, 2026Mirum Pharmaceuticals, Inc. Press Releases
  • Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
    Aug 5, 2026Mirum Pharmaceuticals, Inc. Press Releases
  • Mirum Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026
    Jul 29, 2026Mirum Pharmaceuticals, Inc. Press Releases
  • Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Jul 13, 2026Mirum Pharmaceuticals, Inc. Press Releases
  • Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva
    Jun 14, 2026Mirum Pharmaceuticals, Inc. Press Releases
  • Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Jun 11, 2026Mirum Pharmaceuticals, Inc. Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions